Biohaven and Pfizer announce results of rimegepant trial for acute treatment of migraine
This is the fourth positive phase-III study of rimegepant for the acute treatment of migraine, and the first to be conducted in…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.